Locations:

Research

December 6, 2018/Cancer/Research

Immunosuppressive Therapy Helps Nearly 50 Percent of Patients with Myelodysplastic Syndromes

Study includes largest cohort to date

December 5, 2018/Cancer/Research

Germline Variants in African-American Women with Triple-Negative Breast Cancer

Multigene panel testing valuable regardless of age, cancer history

December 4, 2018/Cancer/Research

Oral Anticoagulants Show Benefit for Cancer Patients at High Risk of Venous Thromboembolism

Prescreening for clots also effective

December 3, 2018/Cancer/Research

Molecular Data Helps Better Predict Survival for Patients with Myelodysplastic Syndrome

Should lead to better treatment

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

December 3, 2018/Cancer/Research

More Evidence that CAR T-Cell Therapy Works for Many Patients with Large B-Cell Lymphoma

High-risk and real-world patients responded

December 2, 2018/Cancer/Research

The Next Step in Immunotherapy for Myeloid Hematologic Malignancies

Study explores atezolizumab for myelodysplastic syndrome

December 2, 2018/Cancer/Research

Good Response Rate for New Anemia Drug in Patients with Myelodysplastic Syndromes

FDA approval may come in 2019

December 1, 2018/Cancer/Research

Blinatumomab Trial: 66 Percent of Patients Achieve Remission from Acute Lymphoblastic Leukemia

Lower toxicity than conventional chemo

November 14, 2018/Cancer/Research

How Nucleophosmin Mutation Causes Acute Myeloid Leukemia

Groundbreaking study paves way for targeted therapy

October 24, 2018/Cancer/Research

IMmotion Update: Understanding the Biomarkers Behind Better Outcomes

Gene signatures differentiate clinical response

BackPage 18 of 27Next